Annual Updates from ASH 2018: Practice Changing Abstracts

Chicago, IL US
February 15, 2019
Our goal is to join community-based providers and academic oncologists to reach our Healthy People 2020 target of 160.0 cancer related deaths per 100,000 individuals or lower. In order to reach this goal, the Annual Updates from ASH 2018: Practice Changing Abstracts addresses early treatment options and medical advances that can be implemented in an effort to reduce cancer related deaths. It will provide physicians and other healthcare professionals with information that will improve their competence and ultimately improve patient outcomes by bridging the gap between the level of care provided in the community and the care provided at an academic medical center. By providing them with important developments from the most recent ASH conference, we want to educate and empower community-based oncologists on best practices for treating hematologic cancers and also inform them of the indicators of when a patient needs to be referred for tertiary level care.
 
Learn more at the conference website!

Target Audience

This activity is designed for physicians and other healthcare professionals interested in the treatment of hematologic cancers.
Additional information
ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
For more information, please contact:
CME Coordinator Contact Name: 
Polly Rossi
CME Coordinator Contact Email: 
CME Coordinator Contact Phone: 
219-465-1115

Learning Objectives

At the conclusion of this activity, participants will be able to:

  • Discuss how comprehension of biology of leukemias has influenced treatment approaches;
  • Describe next generation improvements in CAR T-cell therapies that can improve patient outcomes;
  • Identify methods for integrating therapeutic advances into practice to improve current myeloma patient care;
  • List current best practice in first and second line therapies for lymphoid malignancies;
  • Name new technologies for the treatment of hemophilia;
  • Analyze how new scientific insights are informing diagnosis and treatment of myelodysplastic/myeloproliferative neoplasms.
Summary
Available credit: 
  • 3.75 AMA PRA Category 1 Credit™
  • 3.75 Participation
Event starts: 
02/15/2019 - 1:00pm
Event ends: 
02/15/2019 - 6:00pm
Activity opens: 
02/15/2019
Activity expires: 
05/15/2019

Agenda subject to change.

Gleacher Center
450 Cityfront Plaza Dr
Chicago, IL 60611
United States
Want to know more?
Click here for more information on the Gleacher Center!

 

ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact Polly Rossi via e-mail via at polly@meetingachievements.com.

The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.

COURSE DIRECTOR
  Michael Bishop, MD
  Professor of Medicine
  Director, Hematopoietic Stem Cell Transplantation Program
 
 
 
COURSE FACULTY
Kenneth Cohen, MD
Associate Professor of Medicine
University of Chicago
 
Andrzej Jakubowiak, MD, PhD
Professor of Medicine
University of Chicago
 
Richard Larson, MD
Professor of Medicine
University of Chicago
 
Toyosi Odenike, MD
Associate Professor of Medicine
University of Chicago
 
Peter Riedell, MD
Assistant Professor of Medicine
University of Chicago
 
Stephen Schuster
Professor of Medicine
University of Pennsylvania
 
Sonali Smith, MD
Elwood v. Jensen Professor in Medicine
University of Chicago
 
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
American Board of Internal Medicine MOC Part II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
 
Other Healthcare Professional Credit
Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board. 
 

Please Note: The credit claiming process will close three months after the conference end date. Requests to claim credit after three months will be subject to additional fees.

Accreditation Period

Activity opens: 
02/15/2019
Activity expires: 
05/15/2019
REGISTRATION: To register, click the button below!
 


CLAIMING CREDIT: Enter the access code to unlock the credit claiming process.
Please login or create an account to proceed.